(September 2023)
Access to Effective Medications GLP-1 medications have revolutionized obesity management, offering sustainable results beyond diet and exercise alone
Thus, GLP-1R may be a potential link between DM and AD, and we look forward to discovering more about the mechanism of the link between these two diseases, as well as new applications of GLP-1R agonists in the treatment of AD
GH secretion naturally peaks during deep sleep
These pseudo leukotrienes mimic the structure and function of cysteinyl leukotrienes (CysLTs), inflammatory molecules long associated with airway constriction and mucus production in asthma
Along this line, a recent large case-control study from 2024 including 162,253 obese patients treated with GLP-1 RAs and a matched group of untreated patients found an association between GLP-1 RAs and increased risk of depression, anxiety and suicidal behavior [10]